Nearly 200 Medical School faculty members earned promotions in the 2024 cycle. Their new appointments were approved May 16 by the U-M Board of regents and take effect Sept. 1, 2024.

Four with Medical School ties are among 12 University of Michigan faculty and staff members recognized by the American Association for the Advancement of Science (AAAS) as 2023 fellows in recognition of their extraordinary achievements.

A new urine-based test addresses a major problem in prostate cancer: how to separate the slow growing form of the disease unlikely to cause harm from more aggressive cancer that needs immediate treatment.

At-home test can detect tumor DNA fragments in urine samples, providing a non-invasive alternative to traditional blood-based biomarker tests

Former DCMB PhD student Dr. Shuze Wang was published in Developmental Cell.

Congratulations to incoming intern, Chioma Anidi on being the 2024 recipient of the Albert C. Furstenberg Award

Meet the newest residents to join our program

2 in 3 parents in national poll say their child ages 5-12 use personal audio devices; pediatrician offers 4 tips to reduce noise exposure risks

Elective surgery study shows older adults have concerns about what it will cost them, how much work they’ll miss and whether they’ll catch COVID-19.

With over 400 stories published on Health Lab in 2023, the following 10 articles were the most read of the year.

Metabolism pathways make tumors sensitive or resistant to treatments. A collaborative group leverages these avenues to explore the growing foundation of new potential therapies

As researchers explored potential reasons behind racial disparities in treatment outcomes for children with severe sleep apnea, they were expecting to find the answer in socioeconomic factors. But they were surprised to learn that when one risk factor – obesity – was taken out of the equation, race was no longer associated with worse post-surgery outcomes for obstructive sleep apnea.

Congratulations to Gifty Kwakye, MD, MPH, and Andrew G. Shuman, MD, FACS, HEC-C, on their new roles.

Michigan Medicine researchers looked into a drug in development to treat prostate cancer called proxalutamide, which works by blocking an enzyme called TMPRSS2 (transmembrane protease, serine 2) that is regulated by androgen receptors, as a potential therapeutic for COVID.

A study from clinicians and researchers at the University of Michigan Rogel Cancer Center reveals findings from over 800 clinical assays performed for kidney patients with MiTF family gene mutations.